![Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin - Clara Ting, Katelyn W. Sylvester, James W. Schurr, 2018 Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin - Clara Ting, Katelyn W. Sylvester, James W. Schurr, 2018](https://journals.sagepub.com/cms/10.1177/1076029618798944/asset/images/large/10.1177_1076029618798944-fig1.jpeg)
Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin - Clara Ting, Katelyn W. Sylvester, James W. Schurr, 2018
![Measuring Quality of Oral Anticoagulation Care: Extending Quality Measurement to a New Field - ScienceDirect Measuring Quality of Oral Anticoagulation Care: Extending Quality Measurement to a New Field - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1553725009350199-gr1.jpg)
Measuring Quality of Oral Anticoagulation Care: Extending Quality Measurement to a New Field - ScienceDirect
![Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study | Health and Quality of Life Outcomes | Full Text Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-020-01600-z/MediaObjects/12955_2020_1600_Fig1_HTML.png)
Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study | Health and Quality of Life Outcomes | Full Text
![Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control - ScienceDirect Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718355359-fx1.jpg)
Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control - ScienceDirect
![CPMC-WD therapeutic warfarin dosing (mg/week) and categories based on... | Download Scientific Diagram CPMC-WD therapeutic warfarin dosing (mg/week) and categories based on... | Download Scientific Diagram](https://www.researchgate.net/publication/301697757/figure/fig1/AS:357451422552064@1462234468700/CPMC-WD-therapeutic-warfarin-dosing-mg-week-and-categories-based-on-CYP2C9-VKORC1-and.png)
CPMC-WD therapeutic warfarin dosing (mg/week) and categories based on... | Download Scientific Diagram
![Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK | BMJ Open Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/5/12/e009267/F3.large.jpg)
Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK | BMJ Open
![Warfarin Efficacy in Cancer Patients on Long-term Anticoagulation Neha Doshi, PharmD Candidate LeAnn B. Norris, PharmD, BCPS P. Brandon Bookstaver, PharmD, - ppt download Warfarin Efficacy in Cancer Patients on Long-term Anticoagulation Neha Doshi, PharmD Candidate LeAnn B. Norris, PharmD, BCPS P. Brandon Bookstaver, PharmD, - ppt download](https://images.slideplayer.com/25/8066298/slides/slide_9.jpg)
Warfarin Efficacy in Cancer Patients on Long-term Anticoagulation Neha Doshi, PharmD Candidate LeAnn B. Norris, PharmD, BCPS P. Brandon Bookstaver, PharmD, - ppt download
![Excel template for Rosendaal method Time in Therapeutic Range calculations – Healthcare System Solutions Excel template for Rosendaal method Time in Therapeutic Range calculations – Healthcare System Solutions](http://www.healthcaresystemsolutions.com/wp-content/uploads/edd/2015/02/Rosendaal_Method_Manual_Calculation_Excel_Template_Screenshot.jpg)
Excel template for Rosendaal method Time in Therapeutic Range calculations – Healthcare System Solutions
Guidance on use of Direct Oral Anti-Coagulants (DOACs) and warfarin in non- valvular Atrial Fibrillation Contents
Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis | PLOS ONE
![Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin | Postgraduate Medical Journal Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin | Postgraduate Medical Journal](https://pmj.bmj.com/content/postgradmedj/94/1110/207/F1.large.jpg)